secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENDRA Life Sciences Inc. (NDRA)
CIK:        0001681682
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0001654954-22-016935
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ENDRA Life Sciences CCO Renaud Maloberti resigns effective Jan 13, 2023
-----------------------------------------------------------------------

- Renaud Maloberti resigned as Chief Commercial Officer, effective January 13, 2023.
- Resignation not related to any disagreement with company's operations, policies, or practices.
- No replacement for the CCO position announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681682/000165495422016935/0001654954-22-016935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681682/000165495422016935/ndra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-016935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer